Trading volume was 19.9 times its 30-day average, The stock rose 10.2 percent so far this year.
Shares of the drugmaker rose as much as 8.7 percent, the most in over a year, to trade near a two-month high at Rs 2,655.
Dr Reddys Labs News
Dr. Reddy’s Labs Drops On Repeat Observations For Duvvada Plant
Dr. Reddy’s Labs Drops On Repeat Observations For Duvvada Plant – Shares of the Hyderabad-based drug maker fell as much as 2.61 percent to Rs 2,389 after it received eight observations, five of them a repeat of 2017 and warning letter of 2015, from the U.S. drug regulator at its Duvvada facility—crucial for future growth prospects in its largest market.